Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change Measures
Authors:
- Lana M. ChahineLCLana M. Chahine
- The Parkinson’s Progression Markers InitiativeTIThe Parkinson’s Progression Markers Initiative
Open Access
- 11 October 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 9 (4) , 665-679
Abstract
Background: Improved prediction of Parkinson’s disease (PD) progression is needed to support clinical decision-making and to accelerate research trials. Objectives: To examine whether baseline measures and their 1-year change predict longer-term progKeywords
This publication has 29 references indexed in Scilit:
- Baseline [123I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's diseaseActa Neurologica Scandinavica, 2013
- A Practical Guide to Calculating Cohen’s f2, a Measure of Local Effect Size, from PROC MIXEDFrontiers in Psychology, 2012
- The Parkinson Progression Marker Initiative (PPMI)Progress in Neurobiology, 2011
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- Prognostic factors for the progression of Parkinson's disease: A systematic reviewMovement Disorders, 2007
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUTMovement Disorders, 2004
- Bootstrap investigation of the stability of a cox regression modelStatistics in Medicine, 1989
- The bootstrap and identification of prognostic factors via cox's proportional hazards regression modelStatistics in Medicine, 1985